Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, reflecting a minor update to the page system. No study content or results were changed.
    Difference
    0.0%
    Check dated 2026-07-27T06:19:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a new version of the page metadata rather than a substantive change to the information shown.
    Difference
    0.0%
    Check dated 2026-07-05T10:49:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Page metadata was updated from Revision v3.6.0 to v3.6.2, indicating a minor patch release of the page system. This update does not introduce changes to the study text or data.
    Difference
    0.0%
    Check dated 2026-06-28T06:38:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Recruitment status on the study page now shows 'No longer looking for participants', signaling that enrollment is closed. The page also adds new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), updates the Intervention/Treatment heading formatting, and includes a revision note 'Revision: v3.6.0'.
    Difference
    0.2%
    Check dated 2026-06-14T05:24:53.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a new site revision. No specific content changes are indicated by the provided changes.
    Difference
    0.0%
    Check dated 2026-06-07T02:19:41.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.5.3 to v3.5.4, indicating a new release of the site's backend or content management. This change does not alter trial information shown to users.
    Difference
    0.0%
    Check dated 2026-05-16T09:25:53.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.